Answers are grounded in this paper and cite their sources.
Endothelial senescence contributes to cardiac aging, but the involvement of thioredoxin-interacting protein (TXNIP) in responses to extracellular vesicle (EV) treatment remains unclear. We first examined TXNIP in primate cardiac endothelium, then evaluated EVs from human induced pluripotent stem cell-derived mesenchymal stromal cells (iMSCs) in cellular and mouse models. Exploratory single-cell profiling identified higher TXNIP expression in several cardiac endothelial populations from older rhesus macaques and linked its expression to oxidative stress-, reactive oxygen species- and senescence-associated secretory phenotype-related signatures. Tissue immunofluorescence corroborated increased endothelial-associated TXNIP signals. Under microfluidic flow, iMSCs showed greater retention on stressed endothelium. Direct and Transwell coculture attenuated senescence-associated phenotypes in oxidatively stressed human cardiac microvascular endothelial cells. iMSC-EVs reduced senescence-associated β-galactosidase positivity and TXNIP, p21 and γH2AX levels while increasing proliferative activity and viability. In EV-treated cells, TXNIP overexpression increased p21 and γH2AX levels and senescence-associated β-galactosidase positivity relative to empty-vector controls. In aged mice, iMSC-EVs reduced cardiac endothelial-associated TXNIP and γH2AX signals and increased myocardial oxygen saturation and endothelial nitric oxide synthase phosphorylation at Ser1177 in cardiac tissue. These findings implicate TXNIP in the endothelial response to iMSC-EVs and support further investigation of this intervention in cardiac microvascular aging.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: